the orange line is bristol mier relevant to peers, the s&p 500 health care sector to some extent bristol meyer undershoets and overshoots the great undershoot, great overshoot. thedy veerjens of late appealing to me and more immediately how it's behaving day to day you have the sector up 50% more than bristol going back 30 years to 1990. let's zero in on this and look at the spread. over the past three years, again sector up 27, bristol meyer down 18 bottom fishing is not good it's usually dangerous but if a stock is starting to reverse this and that's what's happening. then it's interesting. lagging dramatically and yet day to day i want to show you the following. here is bristol on top and bristol's relative performance to the seccer. if i put in this line what you see is something very pree precise. it sfald at this line. failed at this line failed at this line. and now it has pushed through. we have broken through meaning relatively outperformance for the first time in a long time. we have the 1-2 setup. the long-term outperformance now starting to come to life look at the chart itself i t

or at least a chartest there is we check the vitals of health care by putting bristol-meyers under microscoperosoft, google, amazon. how to play the final name for the win. >>> plus erwwe're going to keep

or at least a chartest there is we check the vitals of health care by putting bristol-meyers under microscope microsoft, google, amazon. how to play the final name for the win. >>> plus erwwe're going to keep running with the second sports theme. mikey verses nike. tell us what you need to know to out pace the quarterly report next week. it's time risk less and make more "options action" starts now. >> well, not focussed on wall street as they grapple with the best path forward on drug prices chart master to break it all down >> we look at bristol-myers. there's a opportunity. and the orange line is relative to its peers, the s&p health care sector. you see the great over shoot, the great undershoot, over shoot and it's this divergence of late that is appealing to me and then more immediately how a stock is behavening day to day. you've got the sector up some 50% more than bristol. now let's zero in on this and look at the spread so ovthe past three years again sector up 27 bristol-myers down 18. if a stock is starting to reverse this, then it becoming quite interesting. so lagging dramatical

. >> we were talking health care earlier and i said i liked the big pharma names how about bristol meyershigher. >> tim seymour. >> we played fade it or trade it and i was actually trading and in fact i still want to trade it because i think the growth is there. they're finally seeing ad -- >> that means you're a buyer. >> i'm a buyer. >> just checking steve grasso. >> i agree with jpmorgan, apple. i think it's breaking out above that 233 price wait for that to happen. give away the $6 or $7, but apple is my final. >> let me preface this, guy, don't give me any of this crave nonsense go ahead, final trade. >> no, i know, i have feelings too. biogen has been bouncing around the ttboom but it's >>> i'm cramer, welcome to "mad money" my job is to teach you so call me or you with tweet me you want to know the single most useless thing can you do in this business that's easy. the most useless thing can you do as an investor is worry